Peer-influenced content. Sources you trust. No registration required. This is HCN.
Epoch Health
Among those treated with the drug combination, 18 to 22 out of every 100 residents had a seizure within one year, compared to fewer than two per 100 in the general nursing home population.
Geriatrics November 3rd 2025
US Pharmacist
Pharmacists are instrumental in recognizing MOH, counseling patients who rely on analgesics more than twice weekly, and encouraging preventive therapies.
Internal Medicine October 14th 2025
ReachMD
Integrating suzetrigine and cebranopadol into multimodal treatment algorithms may reduce opioid doses, improve patient function and expand options for those at risk of opioid-related harms.
Clinical Pharmacology September 3rd 2025
Drugs.com
“The death of almost one million Americans during the opioid epidemic has been one of the cardinal failures of the public health establishment,” said FDA Commissioner Marty Makary, M.D., M.P.H. “This long-overdue labeling change is only part of what needs to be done — we also need to modernize our approval processes and post-market monitoring so that nothing like this ever happens again.”
Emergency Medicine August 28th 2025
“Lidocaine is not as safe as we think… there is underreporting. I cannot predict an upper limit of the increase.” – Dr. Michael Fettiplace
Anesthesiology August 28th 2025
Conexiant
Retrospective analysis of more than 1.4 million patients revealed dose-dependent cognitive risks, with younger adults experiencing substantially higher dementia and mild cognitive impairment rates.
Family Medicine/General Practice July 23rd 2025